Bullous pemphigoid: towards personalized care

Article Dermatology

Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid A Meta-analysis

Billal Tedbirt et al.

Summary: This meta-analysis revealed that patients with bullous pemphigoid have a 2.93-fold increased 1-year mortality rate compared to the general population, possibly due to the disease itself, adverse effects of treatment, and patients' comorbidities.

JAMA DERMATOLOGY (2021)

Add to Collection

Article Dermatology

International multicentre observational study to assess the efficacy and safety of a 0.5 mg kg(-1) per day starting dose of oral corticosteroids to treat bullous pemphigoid

V. Hebert et al.

Summary: The study assessed the safety and efficacy of oral prednisone in treating bullous pemphigoid, with results showing that a dose of 0.5 mg kg(-1) per day can effectively control disease activity. This treatment option is suitable for patients with mild or moderate BP and good general condition.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Article Dermatology

International multicentre observational study to assess the efficacy and safety of a 0.5 mg kg(-1) per day starting dose of oral corticosteroids to treat bullous pemphigoid

V. Hebert et al.

Summary: The study found that a daily dose of 0.5 mg kg(-1) of oral prednisone is a safe and effective treatment option for patients with mild or moderate bullous pemphigoid, especially those with good general condition.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Letter Dermatology